Clinical Pearls for Individualizing T2DM Therapy with SGLT2 Inhibitors and GLP-1 RAs

Listen in as Dr. Vanita Aroda, Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston and faculty at Harvard Medical School, covers the ever-changing landscape and paradigm shifts in the management of patients with type 2 diabetes.

Recorded September 14, 2021